#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15936	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2219	714.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1543	1543	C	954	C,T	893,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15936	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2219	714.8	0	HET	.	.	.	T1412TGGGGG,TGGGGGG	.	1412	1412	T	1771	1771	T	942	TGGGGG,TGGGGGG	668,162	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15936	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2219	714.8	0	HET	.	.	.	C1525T	.	1525	1525	C	1884	1884	C	812	C,T	589,150	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27990	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3467	804.3	0	.	n	.	0	A20C	SNP	20	20	A	251	251	C	480	C,A	453,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27990	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3467	804.3	0	.	n	.	0	T695C	SNP	695	695	T	926	926	C	884	C,T	810,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27990	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3467	804.3	0	.	n	.	0	A1638G	SNP	1638	1638	A	1869	1869	G	940	G,A	868,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27990	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3467	804.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2202	2202	C	883	C,G	812,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27990	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3467	804.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2276	2276	A	923	A	870	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27990	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3467	804.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	2828	2828	C	922	C	848	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2128	folP	855	855	100.0	folP.l15.c4.ctg.1	1589	133.1	1	SNP	p	R229S	1	.	.	685	687	AGC	1007	1009	AGC	194;197;197	A;G,A;C	178;181,1;177	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5690	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3275	172.8	1	SNP	p	S91F	1	.	.	271	273	TTC	534	536	TTC	207;207;208	T;T;C	199;200;198	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5690	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3275	172.8	1	SNP	p	G95N	0	.	.	283	285	GGC	546	548	GGC	213;210;208	G;G;C	195;194;191	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5690	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3275	172.8	1	SNP	p	D95G	1	.	.	283	285	GGC	546	548	GGC	213;210;208	G;G;C	195;194;191	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1642	mtrR	633	633	99.84	mtrR.l15.c4.ctg.1	1424	114.6	0	.	p	.	0	F184L	NONSYN	550	552	TTC	924	926	TTG	174;176;176	T;T;G	164;165;163	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1642	mtrR	633	633	99.84	mtrR.l15.c4.ctg.1	1424	114.6	1	SNP	p	G45D	0	.	.	133	135	GGC	507	509	GGC	216;219;222	G;G;C	196;195;201	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	838	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	973	85.2	0	.	n	.	0	A197.	DEL	197	197	A	570	570	A	199	A	184	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5416	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3022	178.7	1	SNP	p	D86N	0	.	.	256	258	GAC	564	566	GAC	219;216;214	G;A;C	207;198;203	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5416	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3022	178.7	1	SNP	p	S87R	1	.	.	259	261	CGT	567	569	CGT	214;212;214	C;G;T	203;200;205	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5416	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3022	178.7	1	SNP	p	R87W	0	.	.	259	261	CGT	567	569	CGT	214;212;214	C;G;T	203;200;205	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5416	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3022	178.7	1	SNP	p	R87I	0	.	.	259	261	CGT	567	569	CGT	214;212;214	C;G;T	203;200;205	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5416	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3022	178.7	1	SNP	p	S88P	0	.	.	262	264	TCC	570	572	TCC	216;214;212	T;C;C	206;205;203	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4340	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2603	166.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1523	1525	GGC	227;223;220	G;G;C,T	206;203;196,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4092	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2428	167.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1304	1306	GCA	207;205;202	G;C;A	192;188;187	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4092	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2428	167.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1307	1309	ATC	203;202;205	A;T;C	189;189;191	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4092	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2428	167.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1319	1321	GTG	210;210;215	G;T;G	197;191;195	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4092	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2428	167.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1319	1321	GTG	210;210;215	G;T;G	197;191;195	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4092	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2428	167.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1823	1825	ACC	209;210;210	A,G;C;C	192,1;195;197	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4092	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2428	167.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1877	1879	GCG	184;183;179	G;C;G	160;142;147	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4092	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2428	167.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1877	1879	GCG	184;183;179	G;C;G	160;142;147	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4092	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2428	167.9	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2000	2002	AGC	173;173;172	A;G;C	158;160;158	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4092	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2428	167.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2009	2011	GGC	171;170;168	G;G;C	159;159;156	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4092	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2428	167.9	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2027	2029	CCG	137;138;139	C;C;G	99;101;102	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6010	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3056	195.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1586	1588	CCG	227;229;233	C;C;G	207;215;210	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2306	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1754	130.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	525	525	C	171	C,T	159,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2840	porB1b	1041	1041	96.37	porB1b.l6.c30.ctg.1	1420	197.6	0	.	p	.	0	E48G	NONSYN	142	144	GAA	350	352	GGA	244;245;252	G;G;A	217;217;225	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2840	porB1b	1041	1041	96.37	porB1b.l6.c30.ctg.1	1420	197.6	0	.	p	.	0	V75I	NONSYN	223	225	GTT	431	433	ATT	246;248;248	A;T;T	233;232;233	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2840	porB1b	1041	1041	96.37	porB1b.l6.c30.ctg.1	1420	197.6	0	.	p	.	0	T89S	NONSYN	265	267	ACC	473	475	AGC	210;211;214	A;G;C	193;193;196	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2840	porB1b	1041	1041	96.37	porB1b.l6.c30.ctg.1	1420	197.6	0	.	p	.	0	V98I	NONSYN	292	294	GTC	500	502	ATC	191;187;187	A;T;C	175;170;175	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2840	porB1b	1041	1041	96.37	porB1b.l6.c30.ctg.1	1420	197.6	0	.	p	.	0	.	MULTIPLE	358	359	AA	565	566	CG	217;218	C;G	198;193	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2840	porB1b	1041	1041	96.37	porB1b.l6.c30.ctg.1	1420	197.6	0	.	p	.	0	.	MULTIPLE	361	362	GA	568	570	CAG	219;215;217	C;A;G	201;197;200	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2840	porB1b	1041	1041	96.37	porB1b.l6.c30.ctg.1	1420	197.6	0	.	p	.	0	N122K	NONSYN	364	366	AAC	572	574	AAA	215;214;216	A;A;A	199;200;202	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2840	porB1b	1041	1041	96.37	porB1b.l6.c30.ctg.1	1420	197.6	0	.	p	.	0	F131H	NONSYN	391	393	TTT	599	601	CAT	216;219;222	C;A;T	205;208;209	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2840	porB1b	1041	1041	96.37	porB1b.l6.c30.ctg.1	1420	197.6	0	.	p	.	0	N134E	NONSYN	400	402	AAT	608	610	GAG	216;218;219	G,C;A;G,T	200,1;197;199,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2840	porB1b	1041	1041	96.37	porB1b.l6.c30.ctg.1	1420	197.6	0	.	p	.	0	V135L	NONSYN	403	405	GTG	611	613	CTT	219;218;219	C;T;T	202;199;203	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2840	porB1b	1041	1041	96.37	porB1b.l6.c30.ctg.1	1420	197.6	0	.	p	.	0	G140K	NONSYN	418	420	GGA	626	628	AAA	219;223;222	A;A,T;A	206;209,1;210	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2840	porB1b	1041	1041	96.37	porB1b.l6.c30.ctg.1	1420	197.6	0	.	p	.	0	K143E	NONSYN	427	429	AAA	635	637	GAA	222;221;219	G;A;A	210;206;201	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2840	porB1b	1041	1041	96.37	porB1b.l6.c30.ctg.1	1420	197.6	0	.	p	.	0	V151A	NONSYN	451	453	GTA	659	661	GCA	227;226;222	G;C;A	212;210;204	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2840	porB1b	1041	1041	96.37	porB1b.l6.c30.ctg.1	1420	197.6	0	.	p	.	0	T213S	NONSYN	637	639	ACA	845	847	TCA	233;232;232	T;C;A	216;213;214	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2840	porB1b	1041	1041	96.37	porB1b.l6.c30.ctg.1	1420	197.6	0	.	p	.	0	G253Q	NONSYN	757	759	GGA	965	967	CAA	186;184;186	C;A;A	183;181;183	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2840	porB1b	1041	1041	96.37	porB1b.l6.c30.ctg.1	1420	197.6	0	.	p	.	0	.	INDELS	760	762	ACA	969	973	ATCAA	186;184;181;183;183	A;T;C;A;A	183;179;178;179;180	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2840	porB1b	1041	1041	96.37	porB1b.l6.c30.ctg.1	1420	197.6	0	.	p	.	0	.	INDELS	763	764	TG	976	978	AGT	187;187;187	A;G,T;T	183;182,1;181	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2840	porB1b	1041	1041	96.37	porB1b.l6.c30.ctg.1	1420	197.6	0	.	p	.	0	A257D	NONSYN	769	771	GCT	983	985	GAT	192;194;191	G;A;T,C	182;187;182,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2840	porB1b	1041	1041	96.37	porB1b.l6.c30.ctg.1	1420	197.6	0	.	p	.	0	D293S	NONSYN	877	879	GAT	1091	1093	AGT	290;288;288	A;G;T	266;264;260	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2840	porB1b	1041	1041	96.37	porB1b.l6.c30.ctg.1	1420	197.6	0	.	p	.	0	N295D	NONSYN	883	885	AAC	1097	1099	GAC	284;285;286	G;A;C	262;261;263	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2840	porB1b	1041	1041	96.37	porB1b.l6.c30.ctg.1	1420	197.6	0	.	p	.	0	H296Y	NONSYN	886	888	CAC	1100	1102	TAC	285;282;282	T;A,C;C	264;259,1;262	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2840	porB1b	1041	1041	96.37	porB1b.l6.c30.ctg.1	1420	197.6	1	SNP	p	G120K	1	.	.	358	360	AAG	565	567	CGG	217;218;217	C;G;G	198;193;201	porB1b.WHO_M_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2840	porB1b	1041	1041	96.37	porB1b.l6.c30.ctg.1	1420	197.6	1	SNP	p	D121N	0	.	.	361	363	GAC	568	571	CGC	219;217;217	C;G;C	201;200;202	porB1b.WHO_M_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2840	porB1b	1041	1041	96.37	porB1b.l6.c30.ctg.1	1420	197.6	1	SNP	p	A121D	1	.	.	361	363	GAC	568	571	CGC	219;217;217	C;G;C	201;200;202	porB1b.WHO_M_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11258	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4845	231.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1222	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	890	134.5	1	SNP	p	V57M	1	.	.	169	171	ATG	428	430	ATG	245;243;242	A,G;T;G	226,1;225;225	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
